1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global HER2 Testing Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for HER2 Testing by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for HER2 Testing by Country/Region, 2018, 2022 & 2029
2.2 HER2 Testing Segment by Type
2.2.1 Fluorescence In Situ Hybridization
2.2.2 Dual-Probe
2.2.3 Single-Probe
2.2.4 Chromogenic In Situ Hybridization (CISH)
2.2.5 Silver-Enhanced In Situ Hybridization
2.3 HER2 Testing Sales by Type
2.3.1 Global HER2 Testing Sales Market Share by Type (2018-2023)
2.3.2 Global HER2 Testing Revenue and Market Share by Type (2018-2023)
2.3.3 Global HER2 Testing Sale Price by Type (2018-2023)
2.4 HER2 Testing Segment by Application
2.4.1 Hospitals
2.4.2 Diagnostic Laboratories
2.4.3 Others
2.5 HER2 Testing Sales by Application
2.5.1 Global HER2 Testing Sale Market Share by Application (2018-2023)
2.5.2 Global HER2 Testing Revenue and Market Share by Application (2018-2023)
2.5.3 Global HER2 Testing Sale Price by Application (2018-2023)
3 Global HER2 Testing by Company
3.1 Global HER2 Testing Breakdown Data by Company
3.1.1 Global HER2 Testing Annual Sales by Company (2018-2023)
3.1.2 Global HER2 Testing Sales Market Share by Company (2018-2023)
3.2 Global HER2 Testing Annual Revenue by Company (2018-2023)
3.2.1 Global HER2 Testing Revenue by Company (2018-2023)
3.2.2 Global HER2 Testing Revenue Market Share by Company (2018-2023)
3.3 Global HER2 Testing Sale Price by Company
3.4 Key Manufacturers HER2 Testing Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers HER2 Testing Product Location Distribution
3.4.2 Players HER2 Testing Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for HER2 Testing by Geographic Region
4.1 World Historic HER2 Testing Market Size by Geographic Region (2018-2023)
4.1.1 Global HER2 Testing Annual Sales by Geographic Region (2018-2023)
4.1.2 Global HER2 Testing Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic HER2 Testing Market Size by Country/Region (2018-2023)
4.2.1 Global HER2 Testing Annual Sales by Country/Region (2018-2023)
4.2.2 Global HER2 Testing Annual Revenue by Country/Region (2018-2023)
4.3 Americas HER2 Testing Sales Growth
4.4 APAC HER2 Testing Sales Growth
4.5 Europe HER2 Testing Sales Growth
4.6 Middle East & Africa HER2 Testing Sales Growth
5 Americas
5.1 Americas HER2 Testing Sales by Country
5.1.1 Americas HER2 Testing Sales by Country (2018-2023)
5.1.2 Americas HER2 Testing Revenue by Country (2018-2023)
5.2 Americas HER2 Testing Sales by Type
5.3 Americas HER2 Testing Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC HER2 Testing Sales by Region
6.1.1 APAC HER2 Testing Sales by Region (2018-2023)
6.1.2 APAC HER2 Testing Revenue by Region (2018-2023)
6.2 APAC HER2 Testing Sales by Type
6.3 APAC HER2 Testing Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe HER2 Testing by Country
7.1.1 Europe HER2 Testing Sales by Country (2018-2023)
7.1.2 Europe HER2 Testing Revenue by Country (2018-2023)
7.2 Europe HER2 Testing Sales by Type
7.3 Europe HER2 Testing Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa HER2 Testing by Country
8.1.1 Middle East & Africa HER2 Testing Sales by Country (2018-2023)
8.1.2 Middle East & Africa HER2 Testing Revenue by Country (2018-2023)
8.2 Middle East & Africa HER2 Testing Sales by Type
8.3 Middle East & Africa HER2 Testing Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of HER2 Testing
10.3 Manufacturing Process Analysis of HER2 Testing
10.4 Industry Chain Structure of HER2 Testing
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 HER2 Testing Distributors
11.3 HER2 Testing Customer
12 World Forecast Review for HER2 Testing by Geographic Region
12.1 Global HER2 Testing Market Size Forecast by Region
12.1.1 Global HER2 Testing Forecast by Region (2024-2029)
12.1.2 Global HER2 Testing Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global HER2 Testing Forecast by Type
12.7 Global HER2 Testing Forecast by Application
13 Key Players Analysis
13.1 Abbott
13.1.1 Abbott Company Information
13.1.2 Abbott HER2 Testing Product Portfolios and Specifications
13.1.3 Abbott HER2 Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Abbott Main Business Overview
13.1.5 Abbott Latest Developments
13.2 Hoffmann-La Roche Ltd
13.2.1 Hoffmann-La Roche Ltd Company Information
13.2.2 Hoffmann-La Roche Ltd HER2 Testing Product Portfolios and Specifications
13.2.3 Hoffmann-La Roche Ltd HER2 Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Hoffmann-La Roche Ltd Main Business Overview
13.2.5 Hoffmann-La Roche Ltd Latest Developments
13.3 Agilent Technologies, Inc.
13.3.1 Agilent Technologies, Inc. Company Information
13.3.2 Agilent Technologies, Inc. HER2 Testing Product Portfolios and Specifications
13.3.3 Agilent Technologies, Inc. HER2 Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Agilent Technologies, Inc. Main Business Overview
13.3.5 Agilent Technologies, Inc. Latest Developments
13.4 Thermo Fisher Scientific, Inc.
13.4.1 Thermo Fisher Scientific, Inc. Company Information
13.4.2 Thermo Fisher Scientific, Inc. HER2 Testing Product Portfolios and Specifications
13.4.3 Thermo Fisher Scientific, Inc. HER2 Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Thermo Fisher Scientific, Inc. Main Business Overview
13.4.5 Thermo Fisher Scientific, Inc. Latest Developments
13.5 Leica Biosystems (Danaher Corporation)
13.5.1 Leica Biosystems (Danaher Corporation) Company Information
13.5.2 Leica Biosystems (Danaher Corporation) HER2 Testing Product Portfolios and Specifications
13.5.3 Leica Biosystems (Danaher Corporation) HER2 Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Leica Biosystems (Danaher Corporation) Main Business Overview
13.5.5 Leica Biosystems (Danaher Corporation) Latest Developments
13.6 Empire Genomics, Inc. (Biocare Medical, LLC)
13.6.1 Empire Genomics, Inc. (Biocare Medical, LLC) Company Information
13.6.2 Empire Genomics, Inc. (Biocare Medical, LLC) HER2 Testing Product Portfolios and Specifications
13.6.3 Empire Genomics, Inc. (Biocare Medical, LLC) HER2 Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Empire Genomics, Inc. (Biocare Medical, LLC) Main Business Overview
13.6.5 Empire Genomics, Inc. (Biocare Medical, LLC) Latest Developments
13.7 Bio-Genex Laboratories
13.7.1 Bio-Genex Laboratories Company Information
13.7.2 Bio-Genex Laboratories HER2 Testing Product Portfolios and Specifications
13.7.3 Bio-Genex Laboratories HER2 Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Bio-Genex Laboratories Main Business Overview
13.7.5 Bio-Genex Laboratories Latest Developments
13.8 Abnova Corporation
13.8.1 Abnova Corporation Company Information
13.8.2 Abnova Corporation HER2 Testing Product Portfolios and Specifications
13.8.3 Abnova Corporation HER2 Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Abnova Corporation Main Business Overview
13.8.5 Abnova Corporation Latest Developments
13.9 Oxford Gene Technology IP Limited (Sysmex Corporation)
13.9.1 Oxford Gene Technology IP Limited (Sysmex Corporation) Company Information
13.9.2 Oxford Gene Technology IP Limited (Sysmex Corporation) HER2 Testing Product Portfolios and Specifications
13.9.3 Oxford Gene Technology IP Limited (Sysmex Corporation) HER2 Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Oxford Gene Technology IP Limited (Sysmex Corporation) Main Business Overview
13.9.5 Oxford Gene Technology IP Limited (Sysmex Corporation) Latest Developments
14 Research Findings and Conclusion
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/